Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune diseases, headquartered in Frederick, Maryland. The company is advancing a pipeline of cell therapy candidates targeting serious autoimmune conditions. Cartesian is publicly traded on the Nasdaq exchange.